Burcu Öztürk Şahin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Burcu Öztürk Şahin has a total of 264 co-authors. Here are the top co-authors by number of shared publications:
- Nurdan Kokturk
Department of Pulmonary Diseases, Faculty of Medicine, Gazi University, Ankara, Turkey
6 shared publications - Oya Baydar Toprak
Department of Pulmonary Medicine, Faculty of Medicine, Cukurova University, Adana 01790, Türkiye
4 shared publications - Sümeyye Kodalak Cengiz
Gazi University School of Medicine, Ankara, Türkiye
4 shared publications - Ipek Kivilcim Oguzulgen
Department of Chest Diseases, Gazi University Faculty of Medicine, Ankara, Türkiye
3 shared publications - Umran Ozden Sertcelik
Department of Chest Diseases, Ankara Yıldırım Beyazıt University Faculty of Medicine, Ankara, Türkiye
3 shared publications - Alev Gurgun
Department of Chest Diseases Ege University Faculty of Medicine İzmir Türkiye
2 shared publications
Latest Publications
- Open Access
- 25 August 2026
- Published by Springer Nature in Scientific Reports
Frailty, organ dysfunction and mortality in older ICU patients
- 25 August 2026
- Published by Springer Nature in Scientific Reports
Open AccessFrailty, organ dysfunction and mortality in older ICU patients
- Open Access
- 9 March 2026
- Published by Galenos Yayinevi in Thoracic Research and Practice
Use of Impulse Oscillometry in Patients with Chronic Obstructive Pulmonary Disease
Use of Impulse Oscillometry in Patients with Chronic Obstructive Pulmonary Disease - Thoracic Research and Practice
- 9 March 2026
- Published by Galenos Yayinevi in Thoracic Research and Practice
Open AccessUse of Impulse Oscillometry in Patients with Chronic Obstructive Pulmonary Disease
Use of Impulse Oscillometry in Patients with Chronic Obstructive Pulmonary Disease - Thoracic Research and Practice
- Open Access
- 1 January 2026
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 21, 1-9
Reliability of Pulmonary Function Tests in Patients with Chronic Obstructive Pulmonary Disease
Introduction: Chronic Obstructive Pulmonary Disease (COPD) is frequently underdiagnosed due to limited use and suboptimal quality of spirometry. Methods: This multicenter, prospective observational study aimed to assess the quality of spirometry tests in COPD patients across six tertiary care centers in Turkey. A total of 560 spirometry tests were independently evaluated by two pulmonologists, and inter-rater reliability was analyzed using Cohen’s Kappa. Results: The study included 124 women and 436 men, with a mean age of 65.9± 10.2 years. Spirometry patterns were interpreted as obstructive in 79.1% of tests, restrictive in 5.7%, mixed in 2.7%, normal in 6.7%, inconclusive in 5.5%, and as upper airway obstruction in 0.18% of cases (K=0.890). Routine post-bronchodilator testing was performed in 87.14% of the cases, while 12.85% were post-reversibility tests. Graphical data included volume-time curves (88.5%), flow-volume loops (99.6%), and inspiratory limbs (98.7%). Reference values were predominantly based on ECSC (86.4%), followed by GLI (8.9%) and NHANES (0.25%). Mean spirometric values included FEV1 (% predicted) 57.2%, FVC (% predicted) 72.7%, and FEV1/FVC 61.9%. Cough in the first second of FVC was observed in 17 (3%) (K=0.677), variable or insufficient effort 13.4% (K=0.563), mouth leak 1.8% (K=0.305), mouthpiece obstruction 0.5% (K=0.332), rapid expiration 1.8% (K=0.354), increased concavity 83% (K=0.683), and small airway obstruction 87% (K=0.709) were reported by interpreters. Conclusion: Spirometry reports frequently lack key information such as preliminary diagnoses, test indication, technician, and device details. ECSC is the most commonly used reference. Rates of inconclusive and erroneous tests—due to variable or insufficient effort, mouth leak, mouthpiece obstruction, and rapid expiration—are low.
- 1 January 2026
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 21, 1-9
Open AccessReliability of Pulmonary Function Tests in Patients with Chronic Obstructive Pulmonary Disease
Introduction: Chronic Obstructive Pulmonary Disease (COPD) is frequently underdiagnosed due to limited use and suboptimal quality of spirometry. Methods: This multicenter, prospective observational study aimed to assess the quality of spirometry tests in COPD patients across six tertiary care centers in Turkey. A total of 560 spirometry tests were independently evaluated by two pulmonologists, and inter-rater reliability was analyzed using Cohen’s Kappa. Results: The study included 124 women and 436 men, with a mean age of 65.9± 10.2 years. Spirometry patterns were interpreted as obstructive in 79.1% of tests, restrictive in 5.7%, mixed in 2.7%, normal in 6.7%, inconclusive in 5.5%, and as upper airway obstruction in 0.18% of cases (K=0.890). Routine post-bronchodilator testing was performed in 87.14% of the cases, while 12.85% were post-reversibility tests. Graphical data included volume-time curves (88.5%), flow-volume loops (99.6%), and inspiratory limbs (98.7%). Reference values were predominantly based on ECSC (86.4%), followed by GLI (8.9%) and NHANES (0.25%). Mean spirometric values included FEV1 (% predicted) 57.2%, FVC (% predicted) 72.7%, and FEV1/FVC 61.9%. Cough in the first second of FVC was observed in 17 (3%) (K=0.677), variable or insufficient effort 13.4% (K=0.563), mouth leak 1.8% (K=0.305), mouthpiece obstruction 0.5% (K=0.332), rapid expiration 1.8% (K=0.354), increased concavity 83% (K=0.683), and small airway obstruction 87% (K=0.709) were reported by interpreters. Conclusion: Spirometry reports frequently lack key information such as preliminary diagnoses, test indication, technician, and device details. ECSC is the most commonly used reference. Rates of inconclusive and erroneous tests—due to variable or insufficient effort, mouth leak, mouthpiece obstruction, and rapid expiration—are low.
- Open Access
- 1 December 2025
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 20, 3993-4003
Validation Study of Rome Criteria for Assessing COPD Exacerbation Severity and Predicting Clinical Outcomes: Turkish Thoracic Society COPD Assembly
Objective: The Rome classification was introduced to assess the severity of acute exacerbation (AE) of chronic obstructive pulmonary disease (COPD) based on easily measurable variables. However, its validation for global use has not yet reached a sufficient level. This study aims to evaluate the validity of the Rome criteria in determining the severity and prognosis of COPD AE in Turkey. Methods: This multicenter study, conducted for the first time in Turkey and for the fourth time worldwide, included 750 patients diagnosed with AE-COPD who presented to emergency departments and outpatient clinics. According to the Rome criteria, patients were classified into three groups: mild, moderate, and severe AE-COPD. Results: The study included 99 (13.2%) patients in the mild, 479 (63.9%) in the moderate, and 172 (22.9%) in the severe group. Emergency visits, hospitalizations, and ICU admissions in the past year were more frequent in the moderate and severe groups (p < 0.001 for all comparisons). Regarding outcomes of emergency or outpatient visits, most mild exacerbation cases were discharged (p < 0.001), while most moderate and severe exacerbations required hospitalization (p < 0.001). Compared to the moderate group, the severe exacerbation group had a higher risk of ICU admission (p < 0.001), NIV (p < 0.001), IMV (p < 0.001), in-hospital mortality (p < 0.001), and 30-day mortality (p = 0.015). No significant differences were found in 90-day mortality or 30 and 90-day readmission rates (p = 0.258, p = 0.712, p = 0.681, respectively). Survival analysis revealed no significant difference between the moderate and severe groups (p = 0.764). Conclusion: The findings suggest that the Rome criteria can be successfully used to assess exacerbation severity in AE-COPD patients presenting to secondary and tertiary care hospitals in Turkey.
- 1 December 2025
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 20, 3993-4003
Open AccessValidation Study of Rome Criteria for Assessing COPD Exacerbation Severity and Predicting Clinical Outcomes: Turkish Thoracic Society COPD Assembly
Objective: The Rome classification was introduced to assess the severity of acute exacerbation (AE) of chronic obstructive pulmonary disease (COPD) based on easily measurable variables. However, its validation for global use has not yet reached a sufficient level. This study aims to evaluate the validity of the Rome criteria in determining the severity and prognosis of COPD AE in Turkey. Methods: This multicenter study, conducted for the first time in Turkey and for the fourth time worldwide, included 750 patients diagnosed with AE-COPD who presented to emergency departments and outpatient clinics. According to the Rome criteria, patients were classified into three groups: mild, moderate, and severe AE-COPD. Results: The study included 99 (13.2%) patients in the mild, 479 (63.9%) in the moderate, and 172 (22.9%) in the severe group. Emergency visits, hospitalizations, and ICU admissions in the past year were more frequent in the moderate and severe groups (p < 0.001 for all comparisons). Regarding outcomes of emergency or outpatient visits, most mild exacerbation cases were discharged (p < 0.001), while most moderate and severe exacerbations required hospitalization (p < 0.001). Compared to the moderate group, the severe exacerbation group had a higher risk of ICU admission (p < 0.001), NIV (p < 0.001), IMV (p < 0.001), in-hospital mortality (p < 0.001), and 30-day mortality (p = 0.015). No significant differences were found in 90-day mortality or 30 and 90-day readmission rates (p = 0.258, p = 0.712, p = 0.681, respectively). Survival analysis revealed no significant difference between the moderate and severe groups (p = 0.764). Conclusion: The findings suggest that the Rome criteria can be successfully used to assess exacerbation severity in AE-COPD patients presenting to secondary and tertiary care hospitals in Turkey.
- 10 June 2025
- Published by Bilimsel Tip Publishing House in Tuberk Toraks
- Vol. 73 (2) , 151-155
A rare complication developing after endobronchial ultrasonography-guided transbronchial needle aspiration: Pneumomediastinum
- 10 June 2025
- Published by Bilimsel Tip Publishing House in Tuberk Toraks
- Vol. 73 (2) , 151-155
A rare complication developing after endobronchial ultrasonography-guided transbronchial needle aspiration: Pneumomediastinum
- 11 April 2025
- Published by Elsevier in Respiratory Medicine
- Vol. 242, 108098
Cough burden and quality of life in patients with progressive pulmonary fibrosis: A multicenter observational study
- 11 April 2025
- Published by Elsevier in Respiratory Medicine
- Vol. 242, 108098
Cough burden and quality of life in patients with progressive pulmonary fibrosis: A multicenter observational study
- Open Access
- 29 November 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (48) , e40483
Readmission rates within the first 30 and 90 days after severe COPD exacerbations (RACE study)
Chronic obstructive pulmonary disease (COPD) frequently results in hospital readmission and contributes to increased morbidity and mortality. This multicenter prospective study aimed to identify factors that increase the risk of readmission within 30 to 90 days of severe COPD exacerbation. A total of 415 patients admitted to the emergency department (ED) or general pulmonology ward after discharge due to severe exacerbations from 13 tertiary centers in Turkey were included. Of the participants, 346 (83.4%) were male and 69 (16.6%) were female, with an average age of 69.0 ± 9.1 years. Readmissions within 30 and 90 days after the initial hospitalization occurred in 176 (42.4%) and 191 (46%) patients, respectively. Prospective data collection focused on exacerbation severity, disease severity, and the utility of initial admissions. Factors for 30 to 90 day readmission were analyzed using univariate and multivariate regression models. A 30-day readmission correlated significantly with Hospital Anxiety Depression Scale scores above 16 [odds ratio [OR] 95% confidence intervals [CI]: 1.9 (1.1–3.6); P = .042], severe exacerbation history in the previous year [OR 95% CI: 1.7 (1.1–2.9); P = .038], hospital-acquired pneumonia [OR 95% CI: 1.9 (1–4.1); P = .049)], and frequent antibiotic use in the previous year [OR 95% CI: 1.8 (1.2–2.7); P = .007]. Risk factors for 90-day readmissions included: Grades 3 to 4 tricuspid regurgitation [OR 95% CI: 2.2 (1.1–4.4); P = .024], 2 or more moderate COPD exacerbations [OR 95% CI: 1.9 (1.2–3.1); P = .010], severe exacerbation history in the previous year [OR 95% CI: 2.5 (1.5–4.2); P = .001], immunosuppression [OR 95% CI: 2.7 (1.2–5.7); P = .013], frequent antibiotic use the previous year [OR 95% CI: 1.5 (1–2.4); P = .048], hospitalization via the ED [OR 95% CI: 1.6 (1.1–2.6); P = .028]. To mitigate complications and readmissions, patients with a history of frequent severe COPD exacerbations, high anxiety and depression scores, frequent antibiotic requirements, immunosuppression, tricuspid regurgitation, hospital-acquired pneumonia, and those admitted to the ED should be prioritized for remote monitoring after initial discharge.
- 29 November 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (48) , e40483
Open AccessReadmission rates within the first 30 and 90 days after severe COPD exacerbations (RACE study)
Chronic obstructive pulmonary disease (COPD) frequently results in hospital readmission and contributes to increased morbidity and mortality. This multicenter prospective study aimed to identify factors that increase the risk of readmission within 30 to 90 days of severe COPD exacerbation. A total of 415 patients admitted to the emergency department (ED) or general pulmonology ward after discharge due to severe exacerbations from 13 tertiary centers in Turkey were included. Of the participants, 346 (83.4%) were male and 69 (16.6%) were female, with an average age of 69.0 ± 9.1 years. Readmissions within 30 and 90 days after the initial hospitalization occurred in 176 (42.4%) and 191 (46%) patients, respectively. Prospective data collection focused on exacerbation severity, disease severity, and the utility of initial admissions. Factors for 30 to 90 day readmission were analyzed using univariate and multivariate regression models. A 30-day readmission correlated significantly with Hospital Anxiety Depression Scale scores above 16 [odds ratio [OR] 95% confidence intervals [CI]: 1.9 (1.1–3.6); P = .042], severe exacerbation history in the previous year [OR 95% CI: 1.7 (1.1–2.9); P = .038], hospital-acquired pneumonia [OR 95% CI: 1.9 (1–4.1); P = .049)], and frequent antibiotic use in the previous year [OR 95% CI: 1.8 (1.2–2.7); P = .007]. Risk factors for 90-day readmissions included: Grades 3 to 4 tricuspid regurgitation [OR 95% CI: 2.2 (1.1–4.4); P = .024], 2 or more moderate COPD exacerbations [OR 95% CI: 1.9 (1.2–3.1); P = .010], severe exacerbation history in the previous year [OR 95% CI: 2.5 (1.5–4.2); P = .001], immunosuppression [OR 95% CI: 2.7 (1.2–5.7); P = .013], frequent antibiotic use the previous year [OR 95% CI: 1.5 (1–2.4); P = .048], hospitalization via the ED [OR 95% CI: 1.6 (1.1–2.6); P = .028]. To mitigate complications and readmissions, patients with a history of frequent severe COPD exacerbations, high anxiety and depression scores, frequent antibiotic requirements, immunosuppression, tricuspid regurgitation, hospital-acquired pneumonia, and those admitted to the ED should be prioritized for remote monitoring after initial discharge.
- Open Access
- 10 January 2024
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 25 (1) , 17-25
Factors Associated with Increasing Costs in Severe Chronic Obstructive Pulmonary Disease Exacerbation: Turkish Thoracic Society Chronic Obstructive Pulmonary Disease Assembly
COPD,severe exacerbation,costs,discharge,antibiotic,nutrition,pulmonary rehabilitation
- 10 January 2024
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 25 (1) , 17-25
Open AccessFactors Associated with Increasing Costs in Severe Chronic Obstructive Pulmonary Disease Exacerbation: Turkish Thoracic Society Chronic Obstructive Pulmonary Disease Assembly
COPD,severe exacerbation,costs,discharge,antibiotic,nutrition,pulmonary rehabilitation
- Open Access
- 22 September 2023
- Published by Bilimsel Tip Publishing House in Tuberk Toraks
- Vol. 71 (3) , 261-272
Risk factors for post-acute sequelae of COVID-19 in hospitalized patients: An observational study based on a survey in a tertiary care center in Türkiye
Introduction: Long COVID is a multisystem disease with various symptoms and risk factors. We aim to investigate the post-acute sequelae of COVID-19 and related risk factors in a tertiary care center.Materials and Methods: In this observational study, based on a survey of 1.977 COVID-19 patients hospitalized from April 2020 to January 2021, a retrospective assessment was carried out on 1.050 individuals who were reachable via telephone to determine their eligibility for meeting the inclusion criteria.Results: The data of 256 patients who reported at least one persistent symptom were analyzed. Long COVID prevalence was 24.3%. Among 256 patients (median age 52.8; 52.7% female; 56.63% had at least one comorbidity), dyspnea, fatigue, arthralgia-myalgia, cough, and back pain were the most common post-acute sequelae of COVID-19 (42.4%; 28.29%; 16.33%; 13.15% and 7.17%, respectively). The risk factors for the persistence of dyspnea included having lung diseases such as chronic obstructive pulmonary disease, a history of intensive care support, the requirement for long-term oxygen therapy, and a history of cytokine storm (p= 0.024, p= 0.026, p< 0.001, p= 0.036, p= 0.005, respectively). The correlation between lung involvement with post-discharge cough (p= 0.041) and dizziness (p= 0.038) was significant. No correlation between the symptoms with the severity of acute infection, age, and gender was found. When a multivariate regression analysis was conducted on the most common long COVID-related symptoms, several independent risk factors were identified. These included having lung disease for dyspnea (OR 5.81, 95% CI 1.08-31.07, p= 0.04); length of hospital stay for myalgia (OR 1.034, 95% CI 1.004-1.065, p= 0.024); and pulmonary involvement of over 50% during COVID-19 infection for cough (OR 3.793, 95% CI 1.184-12.147, p= 0.025).Conclusion: COVID-19 survivors will require significant healthcare services due to their prolonged symptoms. We hope that our findings will guide the management of these patients in clinical settings towards best practices.
- 22 September 2023
- Published by Bilimsel Tip Publishing House in Tuberk Toraks
- Vol. 71 (3) , 261-272
Open AccessRisk factors for post-acute sequelae of COVID-19 in hospitalized patients: An observational study based on a survey in a tertiary care center in Türkiye
Introduction: Long COVID is a multisystem disease with various symptoms and risk factors. We aim to investigate the post-acute sequelae of COVID-19 and related risk factors in a tertiary care center.Materials and Methods: In this observational study, based on a survey of 1.977 COVID-19 patients hospitalized from April 2020 to January 2021, a retrospective assessment was carried out on 1.050 individuals who were reachable via telephone to determine their eligibility for meeting the inclusion criteria.Results: The data of 256 patients who reported at least one persistent symptom were analyzed. Long COVID prevalence was 24.3%. Among 256 patients (median age 52.8; 52.7% female; 56.63% had at least one comorbidity), dyspnea, fatigue, arthralgia-myalgia, cough, and back pain were the most common post-acute sequelae of COVID-19 (42.4%; 28.29%; 16.33%; 13.15% and 7.17%, respectively). The risk factors for the persistence of dyspnea included having lung diseases such as chronic obstructive pulmonary disease, a history of intensive care support, the requirement for long-term oxygen therapy, and a history of cytokine storm (p= 0.024, p= 0.026, p< 0.001, p= 0.036, p= 0.005, respectively). The correlation between lung involvement with post-discharge cough (p= 0.041) and dizziness (p= 0.038) was significant. No correlation between the symptoms with the severity of acute infection, age, and gender was found. When a multivariate regression analysis was conducted on the most common long COVID-related symptoms, several independent risk factors were identified. These included having lung disease for dyspnea (OR 5.81, 95% CI 1.08-31.07, p= 0.04); length of hospital stay for myalgia (OR 1.034, 95% CI 1.004-1.065, p= 0.024); and pulmonary involvement of over 50% during COVID-19 infection for cough (OR 3.793, 95% CI 1.184-12.147, p= 0.025).Conclusion: COVID-19 survivors will require significant healthcare services due to their prolonged symptoms. We hope that our findings will guide the management of these patients in clinical settings towards best practices.
- Open Access
- 21 July 2023
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 24 (4) , 231-234
Granulomatous Mediastinitis: A Rare Cause of Pulmonary Hypertension
Anthracosis,anthracofibrosis,fibrosis mediastinitis,biomass exposure,pulmonary hypertension
- 21 July 2023
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 24 (4) , 231-234
Open AccessGranulomatous Mediastinitis: A Rare Cause of Pulmonary Hypertension
Anthracosis,anthracofibrosis,fibrosis mediastinitis,biomass exposure,pulmonary hypertension